Sentinel lymph node biopsy omission in early-stage breast cancer: current evidence and clinical practice
{{output}}
Recent trials (e.g., SOUND, INSEMA) indicate that omitting SLNB in patients with small tumors, negative imaging, and favorable prognoses maintains outcomes, reduces complications, and improves quality of life (3,4). Specifically, the INSEMA trial demonstrated ... ...
